BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26397239)

  • 1. Stage I-II follicular lymphoma: an endangered species?
    McLaughlin P; Seymour JF
    Leuk Lymphoma; 2015; 56(8):2229-30. PubMed ID: 26397239
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma.
    Cencini E; Fabbri A; Schiattone L; Bartalucci G; Bocchia M
    Leuk Lymphoma; 2015; 56(10):2997-8. PubMed ID: 25721753
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
    Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
    Leuk Lymphoma; 2015; 56(8):2350-6. PubMed ID: 25426666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab.
    Quackenbush RC; Horner TJ; Williams VC; Giampietro P; Lin TS
    Leuk Lymphoma; 2015 Mar; 56(3):779-81. PubMed ID: 24898665
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current treatment strategies for follicular lymphoma].
    Hiddemann W; Hoster E; Schmidt C; Dreyling M; Unterhalt M
    Internist (Berl); 2016 Mar; 57(3):222-9. PubMed ID: 26842683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of "watch and wait" in intestinal follicular lymphoma in rituximab era.
    Tari A; Asaoku H; Takata K; Fujimori S; Tanaka S; Fujihara M; Koga T; Yoshino T
    Scand J Gastroenterol; 2016 Mar; 51(3):321-8. PubMed ID: 26382560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.
    Cencini E; Puccini B; Rigacci L; Fabbri A; Kovalchuk S; Mannelli L; Benelli G; Carfagno T; Simontacchi G; Bocchia M; Bosi A
    Leuk Lymphoma; 2018 Jun; 59(6):1420-1426. PubMed ID: 28994343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant B-Cell Lymphoma: Advances in the Therapy of Follicular Lymphoma and Mantle-cell Lymphoma].
    Buske C; Dreyling M
    Dtsch Med Wochenschr; 2018 Jan; 143(1):46-51. PubMed ID: 29316585
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary Duodenal Follicular Lymphoma Treated With Rituximab Monotherapy and Followed-up for 15 Years.
    Seki A; Iwamuro M; Yoshioka M; Fujii N; Okada H; Nose S; Takata K; Yoshino T; Yamamoto K
    Acta Med Okayama; 2015; 69(5):301-6. PubMed ID: 26490027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary follicular lymphoma of the cervix uteri: a review.
    Korcum AF; Karadogan I; Aksu G; Aralasmak A; Erdogan G
    Ann Hematol; 2007 Sep; 86(9):623-30. PubMed ID: 17583814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma.
    Jacobson CA; Freedman AS
    Curr Hematol Malig Rep; 2016 Jun; 11(3):218-23. PubMed ID: 26995595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow infiltration of CD20-negative follicular lymphoma after rituximab therapy: a histological mimicker of hematogones and B-cell acute lymphoblastic leukemia/lymphoma.
    Matsuda I; Hirota S
    Int J Clin Exp Pathol; 2015; 8(8):9737-41. PubMed ID: 26464748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database.
    Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Hamouzova J; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
    Leuk Lymphoma; 2016 May; 57(5):1094-103. PubMed ID: 26293000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma.
    Zhou X; Wang J; Zhang J; Copley-Merriman C; Torigoe Y; Reyes C; Seymour JF; Offner FC; Trneny M; Salles GA
    Hematology; 2015 Apr; 20(3):129-36. PubMed ID: 25029908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of stem-cell transplantation for follicular non-hodgkin lymphoma in the rituximab era?
    Schouten HC
    J Clin Oncol; 2013 May; 31(13):1617-8. PubMed ID: 23547074
    [No Abstract]   [Full Text] [Related]  

  • 16. Follicular lymphoma presenting follicular papules in the skin: A case report.
    Ozaki S; Funasaka Y; Shimizu A; Kawarasaki M; Kanzaki A; Matano Y; Futagami A; Yamaguchi H; Sugisaki Y; Saeki H
    J Dermatol; 2017 Jan; 44(1):111-113. PubMed ID: 27153936
    [No Abstract]   [Full Text] [Related]  

  • 17. Individualized management of follicular lymphoma.
    Bai B; Huang HQ
    Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the optimal management of early-stage low-grade follicular lymphoma in the modern era?
    Vargo JA; Gill BS; Balasubramani GK; Beriwal S
    Cancer; 2015 Sep; 121(18):3325-34. PubMed ID: 26042364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab maintenance in follicular lymphoma.
    Barr PM
    Clin Adv Hematol Oncol; 2015 Mar; 13(3):158-61. PubMed ID: 26352422
    [No Abstract]   [Full Text] [Related]  

  • 20. Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab.
    Scaramucci L; Perrotti A; Niscola P; Fratoni S; Palombi M; Piccioni D; Cupelli L; Tendas A; Dentamaro T; Del Poeta G; De Fabritiis P
    Leuk Lymphoma; 2007 Sep; 48(9):1878-80. PubMed ID: 17786731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.